A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors - Concepedia

Concepedia

Publication | Closed Access

A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors

61

Citations

34

References

2014

Year

E. Gabriela Chiorean, Christopher Sweeney, Hagop Youssoufian, Amy Qin, Aruna Dontabhaktuni, Nick Loizos, Johannes Nippgen, Robert J. Amato

Cancer Chemotherapy and Pharmacology

MedicineImmunologyAdvanced Solid TumorsCancer TreatmentMonoclonal AntibodyOncologyRadiation OncologyTumor BiologyCancer Growth

References

	Year	Citations

Page 1